Disclosures for "Seizure Forecasting and Detection with Wearable Devices and Subcutaneous EEG – Outcomes from the My Seizure Gauge Trial")
-
Dr. Brinkmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka Pharmaceuticals. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Brinkmann has a non-compensated relationship as a Co-Investigator with Medtronic Inc. that is relevant to AAN interests or activities.
-
Dr. Nurse has received stock or an ownership interest from Seer Medical. The institution of Dr. Nurse has received research support from MTPConnect.
-
The institution of Dr. Viana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG Medical.
-
Mona Nasseri has nothing to disclose.
-
Dr. Kuhlmann has nothing to disclose.
-
Dr. Karoly has received personal compensation for serving as an employee of Seer Medical. Dr. Karoly has received stock or an ownership interest from Seer Medical. An immediate family member of Dr. Karoly has received stock or an ownership interest from Seer Medical. The institution of Dr. Karoly has received research support from Australian Government National Health & Medical Research Council. Dr. Karoly has received intellectual property interests from a discovery or technology relating to health care.
-
Tal Pal Attia has nothing to disclose.
-
Nicholas M. Gregg, MD has nothing to disclose.
-
Boney Joseph has nothing to disclose.
-
Mr. Dümpelnann has nothing to disclose.
-
Dr. Cook has received personal compensation for serving as an employee of Seer Medical Pty Ltd. Dr. Cook has received personal compensation for serving as an employee of EpiMinder Pty Ltd. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cook has stock in EpiMinder Pty Ltd . Dr. Cook has stock in Seer Medical Pty Ltd . The institution of Dr. Cook has received research support from NHMRC. Dr. Cook has received intellectual property interests from a discovery or technology relating to health care. Dr. Cook has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
-
Andreas Schulze-Bonhage has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL, GW. Andreas Schulze-Bonhage has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BIAL, GW, EISAI, UCB.
-
The institution of Dr. Richardson has received research support from Medical Research Council UK. The institution of Dr. Richardson has received research support from Epilepsy Research UK. The institution of Dr. Richardson has received research support from GW Pharma. The institution of Dr. Richardson has received research support from European Commission. The institution of Dr. Richardson has received research support from Autifony Therapeutics . The institution of Dr. Richardson has received research support from Epilepsy Foundation of America . Dr. Richardson has received intellectual property interests from a discovery or technology relating to health care.
-
Dean Freestone has nothing to disclose.